ImmunoPET with Zirconium-89 specifically detects postoperative biofilm-associated implant infections: a preclinical study [0.03%]
一种基于免疫的PET显像术能用锆-89来特异性检测与术后生物膜相关的移植物感染：一项临床前研究
F Ruben H A Nurmohamed,Kevin J H Allen,Connor Frank et al.
F Ruben H A Nurmohamed et al.
[18F]FDG WBC labelled PET/CT for the diagnosis of infectious disease: initial experience in a tertiary centre [0.03%]
[18F]FDG标记的白细胞正电子发射型计算机断层扫描/X线计算机体层成像诊断感染性疾病的价值：一家三级医疗机构的初步研究
Christel Hermann Kamani,Julien Costes,Maxime Panchaud et al.
Christel Hermann Kamani et al.
Preclinical in vivo dosimetry of healthy tissues in radiopharmaceutical therapy: implementation of a physiologically realistic mouse eye model in GATE [0.03%]
放射性药物治疗中健康组织的临床前体内剂量学：在GATE中实现生理现实的小鼠眼睛模型
Elodie Jouberton,Nicolas Sas,Tommy Billoux et al.
Elodie Jouberton et al.
Enhanced in-vivo persistence and PET imaging performance of [68Ga]Ga-DOTA-TMVP1446/GS5 as a VEGFR-3 radiotracer [0.03%]
一种VEGFR-3示踪剂[68Ga]Ga-DOTA-TMVP1446/GS5的体内持久性增强及PET显像性能研究
Jing Wang,Xi Chen,Sixuan Cheng et al.
Jing Wang et al.
Background: Vascular endothelial growth factor receptor-3 (VEGFR-3) is overexpressed in tumor-induced lymphangiogenesis. TMVP1446/GS5 is a peptide analogue specifically targeting VEGFR-3, developed through substitution of...
Biodistribution, radiodosimetry and pharmacokinetics of [18F]GSK1482160 for cerebral P2X7 receptor in living subjects [0.03%]
[18F]GSK1482160在活体内的生物分布、放射剂量学和药代动力学用于检测脑P2X7受体
Lei Bi,Kun He,Lu Wang et al.
Lei Bi et al.
FAPi-PET/CT as surrogate marker for subclinical myocardial fibrosis is a prognostic tool for patients undergoing left-sided heart valve surgery [0.03%]
FAPi-PET/CT作为亚临床心肌纤维化的替代标志物可作为接受左心瓣膜手术患者的预后工具
Theresa Holst,Alexander Dierks,Marianne Patt et al.
Theresa Holst et al.
Background: The aim of this study was to evaluate fibroblast activation protein (FAP)-targeted positron emission tomography and computed tomography (PET/CT) imaging as surrogate marker for cardiac fibrosis and therefore a...
Using advanced cell models for targeted radionuclide therapy evaluation: increased efficacy in 3D versus 2D [0.03%]
使用高级细胞模型进行靶向放射性核素治疗评估：与二维相比，三维的疗效增强
Maria J Klomp,Sigrun E Erkens,Lilian van den Brink et al.
Maria J Klomp et al.
Background: Preclinically, radiopharmaceuticals are currently mainly evaluated in two-dimensional (2D) cell models, which lack clinical features that are relevant for accurate evaluation of targeted radionuclide therapy (...
Evaluation of a clinically efficient [18F]FDG PET/CT protocol: short dynamic and two-phase static imaging for differentiating malignant pulmonary lesions [0.03%]
评估一种临床高效的[18F]FDG PET/CT协议：短期动态和两阶段静态成像鉴别恶性肺结节的有效性研究
Yingqin Jia,Rui Qiu,Chunlei Han et al.
Yingqin Jia et al.
Background: Pulmonary lesions affect a large population globally, posing huge challenges in clinical management and public healthcare. Functional imaging-based diagnosis facilitates the classification and treatment planni...
Multi-organ glucose metabolism alterations in diabetes mellitus: a total-body 18F-FDG PET/CT study [0.03%]
糖尿病多器官葡萄糖代谢改变的全身研究：18F-FDG PET/CT表現
Minghua Wang,Lubing Sun,Yaping Wu et al.
Minghua Wang et al.
[68Ga]Ga-HER2 Affibody PET/CT for early prediction of neoadjuvant therapy outcome in HER2-positive breast cancer: a preliminary report [0.03%]
68镓-Ga-HER2 Affibody PET/CT在预测新辅助治疗前乳腺癌患者治疗效果的初步研究
Yuhan Sun,Ran An,Ruoxi Yang et al.
Yuhan Sun et al.